Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin Renal Biomarkers in Diabetic Nephropathy
NCT04521049Phase 4Completed
- Sponsor
- Beni Suef University
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in diabetic nephropathy (DN), sponsored by Beni Suef University. Started Mar 2019; status: completed.
02
Drugs
saxagliptin
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT04521049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521049.